Hui-juan Cui
Chinese Academy Of Sciences Shandong Road 145
Shanghai, 200001, China
Shanghai, 200001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Research progress on the hallmarks of radiation-induced intestinal injury: Mechanisms, biomarkers and therapeutic targets.
Journal: Archives of biochemistry and biophysics
Published: March 11, 2025
Gegen Qinlian Tablets attenuate immune-related adverse events in NSCLC patients: A multi-center randomized controlled trial in China.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 11, 2025
The effect of Baduanjin on postoperative activity tolerance, lung function and negative emotions in patients with lung cancer: a systematic review and meta-analysis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 10, 2025
Management of Regorafenib-Induced Hand-Foot Skin Reaction with Topical Chinese Medicine and Urea Ointment: A Case Report and Literature Review.
Journal: OncoTargets and therapy
Published: December 06, 2024
Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial.
Journal: Chinese medicine
Published: June 05, 2024
Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 16, 2024
Letter re: Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 02, 2022
Suggestions on "Pathological complete response to neoadjuvant chemoimmunotherapy correlates with peripheral blood immune cell subsets and metastatic status of mediastinal lymph nodes (N2 lymph nodes) in non-small cell lung cancer".
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 03, 2022
Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge.
Journal: JAMA oncology
Published: September 24, 2020
Body mass index: Another way to predict the efficacy of immune checkpoint inhibitors?
Journal: International immunopharmacology
Published: March 08, 2020
Last Updated: 09/26/2026